What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Cognition
His primary areas of study are Cognition, Glioma, Quality of life, Internal medicine and Neuropsychology.
His Cognition research includes elements of Developmental psychology, Resting state fMRI and Clinical psychology.
His work carried out in the field of Glioma brings together such families of science as Neurocognitive and Neuroscience.
His Quality of life research is multidisciplinary, incorporating perspectives in Physical therapy, Surgery and Disease.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Radiation therapy, Clinical endpoint and Bevacizumab.
His study in Neuropsychology is interdisciplinary in nature, drawing from both Verbal memory and Pediatrics.
His most cited work include:
- Cognitive deficits in adult patients with brain tumours. (516 citations)
- Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study (451 citations)
- Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up (445 citations)
What are the main themes of his work throughout his whole career to date?
Martin Klein focuses on Internal medicine, Cognition, Glioma, Oncology and Quality of life.
His Internal medicine research includes themes of Neurocognitive, Type 1 diabetes, Surgery and Cardiology.
In his study, which falls under the umbrella issue of Cognition, Psychiatry is strongly linked to Clinical psychology.
In Glioma, Martin Klein works on issues like Magnetoencephalography, which are connected to Resting state fMRI.
His Oncology research incorporates elements of Bevacizumab, Chemotherapy, Temozolomide, Low-Grade Glioma and Brain tumor.
His Quality of life study incorporates themes from Physical therapy, Neurology and Pediatrics.
He most often published in these fields:
- Internal medicine (35.23%)
- Cognition (32.38%)
- Glioma (22.42%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (35.23%)
- Cognition (32.38%)
- Oncology (21.35%)
In recent papers he was focusing on the following fields of study:
Martin Klein spends much of his time researching Internal medicine, Cognition, Oncology, Glioma and Neurocognitive.
His study in the field of Temozolomide, Bevacizumab, Clinical endpoint and Randomized controlled trial is also linked to topics like In patient.
He interconnects Type 1 diabetes and Cognitive decline in the investigation of issues within Cognition.
His Oncology study integrates concerns from other disciplines, such as Progression-free survival, Chemotherapy, Brain tumor, Hazard ratio and Radiation therapy.
His research investigates the connection with Glioma and areas like Magnetoencephalography which intersect with concerns in Epilepsy.
His Neurocognitive research is multidisciplinary, relying on both Quality of life, Health related quality of life, Quality of life and Intensive care medicine.
Between 2016 and 2021, his most popular works were:
- Lomustine and Bevacizumab in Progressive Glioblastoma (281 citations)
- Large and fast human pyramidal neurons associate with intelligence (51 citations)
- Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol (40 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Cognition
His primary areas of investigation include Internal medicine, Cognition, Glioma, Oncology and Cognitive decline.
He has included themes like Neurocognitive and Neuropsychological assessment in his Internal medicine study.
His work deals with themes such as Lateralization of brain function, Type 1 diabetes and Magnetoencephalography, which intersect with Cognition.
The study incorporates disciplines such as Clinical trial, Medical physics, Protocol and Medical education in addition to Glioma.
His work is dedicated to discovering how Oncology, Hazard ratio are connected with Proportional hazards model and Tumor progression and other disciplines.
His studies deal with areas such as Prospective cohort study and Neuropsychology as well as Cognitive decline.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
